The Impact of Contract Research Organizations (CRO) Bureaucracy in Clinical Trial Conduction: a Model from Lung Cancer

Although CRO support is commonly included in clinical trials conduction, its hypothetical impact in term of timesaving and benefit has never been quantified. With this aim, we retrospectively analyzed 113 lung cancer trials to evaluate activation timelines and patients accrual according to CRO involvement. The exploratory results of our analysis suggest that bureaucratic procedures might require more time in the CRO-administered trials compared to sponsor-administered and CRO-free studies, which also result in a superior number of patients screening and enrollment.

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2ySTYIx
via IFTTT